Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Bayer : Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 45596) - Meeting

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/02/2017 | 07:44pm CEST

TIME: 8:30 a.m.

EVENT: Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 45596) holds a meeting of the Antimicrobial Drugs Advisory Committee to discuss new drug application 209367, ciprofloxacin inhalation powder, sponsored by Bayer HealthCare Pharmaceuticals, Inc., for the proposed indication of reduction of exacerbations in non-cystic fibrosis bronchiectasis adult patients with respiratory bacterial pathogens.

DATE: November 16, 2017

LOCATION: FDA White Oak Campus, 10903 New Hampshire Avenue, Building 31 Conference Center, the Great Room, Room 1503, Silver Spring, Md.

CONTACT: Lauren Tesh, 301-796-9001, AMDAC@fda.hhs.gov

Copyright (c) 2017 Federal Information & News Dispatch, Inc., source Washington Daybook

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
08:48aBAYER : Verdict In Weed Killer Case Hits Bayer -- WSJ
DJ
08/13BAYER : Shares Plunge After Monsanto Weed Killer Ruling -- 3rd Update
DJ
08/13BAYER : Shares Plunge After Monsanto Weed Killer Ruling -- 2nd Update
DJ
08/13GERMANY AIMS TO END USE OF GLYPHOSAT : spokesman
RE
08/13Roundup cancer verdict sends Bayer shares sliding
RE
08/13Roundup cancer verdict sends Bayer shares sliding
RE
08/13BAYER : Shares Plunge After Monsanto Weed Killer Ruling -- Update
DJ
08/13BAYER : #18-1423 Recalculation of reference value for certain instrument with Ba..
AQ
08/13BAYER : Germany aims to end use of glyphosate in this legislative period-spokesm..
RE
08/13BAYER : Shares Wilt After Monsanto Weed Killer Ruling
DJ
More news
News from SeekingAlpha
08/13Bayer drops to five-year low on Roundup verdict, sinks Scotts Miracle-Gro 
08/13U.S. Likely To Follow Global Stocks Lower As Turkish Lira Tumbles (Wall Stree.. 
08/13FDA rejects Regeneron's application for 12-week dosing of Eylea for wet AMD 
08/13WALL STREET BREAKFAST : U.S. Likely To Follow Global Stocks Lower As Turkish Lir.. 
08/13Bayer plunges after Monsanto ordered to pay $289M in California cancer trial 
Financials (€)
Sales 2018 39 152 M
EBIT 2018 7 845 M
Net income 2018 4 895 M
Debt 2018 33 029 M
Yield 2018 3,32%
P/E ratio 2018 17,04
P/E ratio 2019 15,00
EV / Sales 2018 3,07x
EV / Sales 2019 2,54x
Capitalization 87 063 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 114 €
Spread / Average Target 37%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-18.19%99 237
JOHNSON & JOHNSON-6.42%350 770
PFIZER13.00%239 423
NOVARTIS-0.87%209 596
ROCHE HOLDING LTD.-3.39%207 317
MERCK AND COMPANY17.42%175 715